Mandalam Ramkumar 4
4 · Cryoport, Inc. · Filed Jun 8, 2026
Research Summary
AI-generated summary of this filing
Cryoport Director Mandalam Ramkumar Sells 23,214 Shares, Receives Awards
What Happened
Mandalam Ramkumar, a director of Cryoport, sold 23,214 shares in an open-market transaction on 2026-06-08 at a weighted average price of $15.44, for proceeds of approximately $358,452. On 2026-06-05 he was also granted awards totaling 26,427 rights (10,350 restricted stock rights and 16,077 derivative awards) at $0.00 (no cash paid).
Key Details
- Sale: 23,214 shares on 2026-06-08; weighted average price $15.44; total reported proceeds $358,452. (Footnote: sale prices ranged $15.40–$15.48; seller can provide per-trade breakdown.)
- Awards: Two grants dated 2026-06-05 — 10,350 restricted stock rights and 16,077 derivative awards, reported at $0.00.
- Shares owned after the transaction: Not specified in the provided report.
- Vesting/other footnotes:
- F1: The 10,350 restricted stock rights vest in full on June 5, 2027 and convert one-for-one to common stock upon vesting.
- F3: The 16,077 derivative awards vest 1/12th on the 5th of each month for 12 months beginning July 5, 2026.
- F2: Weighted-average sale price and price range disclosure; breakdown available on request.
- Filing timeliness: Form 4 filed 2026-06-08; the filing does not indicate a late report.
Context
The sale was an open-market disposal (S) and the awards are non-cash compensation/derivative grants (A). The restricted stock rights will convert to common shares only after vesting (F1); the derivative awards vest monthly over a year (F3). These award grants are acquisitions on paper but involve no cash outlay at grant. The filing is factual and does not state the insider’s motivation.
Insider Transaction Report
- Award
Common Stock
[F1]2026-06-05+10,350→ 91,108 total - Sale
Common Stock
[F2]2026-06-08$15.44/sh−23,214$358,452→ 67,894 total - Award
Option (Right to Buy Common Stock)
[F3]2026-06-05+16,077→ 16,077 totalExercise: $15.70Exp: 2033-06-05→ Common Stock (16,077 underlying)
Footnotes (3)
- [F1]Reflects grant of restricted stock rights that vest in full on June 5, 2027, and upon vesting automatically convert to shares of common stock on a one-for-one basis.
- [F2]The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $15.40 to $15.48, inclusive. The reporting person undertakes to provide to Cryoport, Inc., any security holder of Cryoport, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F3]1/12th of the options vest on the 5th of the month for twelve months beginning July 5, 2026.